Lin has strong expertise in the cell therapy field from regulatory, quality control to R&D positions. He is interested in developing cell therapy products to treat solid tumors. He is seasoned immunologist with background with broad knowledge in infectious diseases, autoimmune diseases and immuno-oncology.
He has previously worked at Sorrento Therapeutics, a clinical stage cell therapy company. Lin graduated from University of North Carolina with a Ph.D degree.